Trigeminal Neuralgia

• FDA approval · 2010-01-27
  FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a Supplemental Application for carbamazepine by Sun Pharmaceutical Industries, Inc. under an ANDA, marking an approved change t…

• FDA approval · 2009-12-15
  FDA Approved: CARBAMAZEPINE — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for Carbamazepine (generic) submitted by Chartwell RX, LLC.

• FDA approval · 2009-11-25
  FDA Approved: CARBAMAZEPINE — Supplemental Application (Apotex Corp.)

  FDA approved a supplemental application for Carbamazepine from Apotex Corp.

• FDA approval · 2009-11-18
  FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)

  FDA approved a supplemental application for Carbamazepine by Torrent Pharmaceuticals Limited to update labeling.

• FDA approval · 2009-11-04
  FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for EPITOL (carbamazepine) from Teva Pharmaceuticals USA, Inc. The document does not specify the cha…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2009-04-23
  FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for TEGRETOL (carbamazepine) submitted by Novartis Pharmaceuticals Corporation.

• FDA approval · 2009-04-23
  FDA Approved: TEGRETOL XR — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for Tegretol XR (carbamazepine) submitted by Novartis Pharmaceuticals, indicating an approved modifi…

• FDA approval · 2009-03-31
  FDA Approved: CARBAMAZEPINE — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved Sun Pharmaceutical Industries' generic carbamazepine via an original ANDA. It is used to treat epilepsy and trigeminal neuralgi…

• CLINICAL_TRIALS research · 2009-03-20
  Clinical Trial Update: Clinical Trial of Hyperbaric Oxygen Treatment in Trigeminal Neuralgia Patients [Phase 1, Phase 2]

  Clinical trial update on hyperbaric oxygen therapy for trigeminal neuralgia (Phase 1/Phase 2).

• FDA approval · 2008-07-28
  FDA Approved: CARBAMAZEPINE — Supplemental Application (Apotex Corp.)

  FDA approved Apotex Corp.'s supplemental application for carbamazepine (generic), signifying approval of a supplemental ANDA for this produc…

• FDA approval · 2008-04-21
  FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a supplemental application for carbamazepine from Sun Pharmaceutical Industries, Inc., updating the approved generic product un…

• FDA approval · 2008-04-17
  FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc.

• CLINICAL_TRIALS trial_result · 2008-04-16
  Clinical Trial Update: EEG Monitoring to Assess Emergence From Neuroanesthesia [NA]

  The University of Manitoba conducted a completed trial evaluating EEG monitoring to assess emergence from neuroanesthesia in patients with c…

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Studies of Dextromethorphan and Topiramate to Treat Oral and Facial Pain [Phase 2]

  Phase 2 clinical trial evaluating dextromethorphan and topiramate for oral and facial pain, including facial neuralgia and trigeminal neural…

• FDA approval · 2008-02-11
  FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)

  FDA approved Torrent Pharmaceuticals Limited's supplemental application for carbamazepine, a generic anticonvulsant. The approval updates th…

• FDA approval · 2008-02-11
  FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)

  FDA approved a supplemental application for a generic Carbamazepine product from Torrent Pharmaceuticals Limited (ANDA 077272).

• FDA approval · 2008-01-11
  FDA Approved: CARBAMAZEPINE — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for carbamazepine submitted by Chartwell RX, LLC for an existing generic product.

• FDA approval · 2007-12-26
  FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)

  FDA approved a supplemental application for carbamazepine from Torrent Pharmaceuticals Limited.

• FDA approval · 2007-12-17
  FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)

  The FDA approved Torrent Pharmaceuticals Limited's supplemental application for Carbamazepine, a generic antiepileptic. The action updates t…

• FDA approval · 2007-12-11
  FDA Approved: TEGRETOL XR — Supplemental Application (Novartis Pharmaceuticals Corporation)

  The FDA approved a supplemental application for Tegretol XR (carbamazepine) from Novartis Pharmaceuticals Corporation.

• FDA approval · 2007-12-11
  FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)

  The FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation.

• FDA label_change · 2007-12-11
  FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)

  The FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation. The update concerns …

• FDA approval · 2007-08-16
  FDA Approved: TEGRETOL XR — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for Tegretol XR (carbamazepine) submitted by Novartis Pharmaceuticals Corporation.

• FDA approval · 2007-08-16
  FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation; the approval updates the…